Waters Corp (WAT)

WAT (NYSE:Health Services) EQUITY
pos +0.00
Today's Range: 115.46 - 119.39 | WAT Avg Daily Volume: 491,500
Last Update: 10/02/15 - 4:03 PM EDT
Volume: 0
YTD Performance: 5.85%
Open: $0.00
Previous Close: $117.36
52 Week Range: $93.56 - $137.39
Oustanding Shares: 82,270,353
Market Cap: 9,655,248,628
6-Month Chart
TheStreet Ratings Grade for WAT
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 5 4 3 2
Moderate Buy 0 0 0 0
Hold 8 9 9 10
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.38 2.52 2.64 2.79
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 21.22
Price Earnings Comparisons:
WAT Sector Avg. S&P 500
21.22 21.20 24.21
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-7.78% 22.77% 42.02%
Revenue 4.50 0.07 0.02
Net Income -4.10 0.00 0.00
EPS -2.50 0.07 0.02
Earnings for WAT:
Revenue 1.99B
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

bullishWaters upgraded at BofA/Merrill

Sep 10, 2015 | 7:41 AM EDT

WAT was upgraded from Neutral to Buy, Bank of America/Merrill Lynch said. $140 price target. Stock has pulled back, but the company can deliver double-digit annual earnings growth over the next few years. 

bullishWaters upgraded at Wells

Jul 29, 2015 | 8:03 AM EDT

WAT was upgraded from Market Perform to Outperform, Wells Fargo said. Company's biopharma strength is sustainable. 


Paul Price

 | Nov 4, 2014 | 3:00 PM EST

Remember: It's optional.


Paul Price

 | Oct 1, 2014 | 9:00 AM EDT

This solid niche manufacturing name offers high quality at a reasonable price. Here's how to get in.

bearishWaters downgraded at BofA/Merrill

Oct 23, 2013 | 8:04 AM EDT

WAT was downgraded to Neutral from Buy, Bank of America/Merrill Lynch said. $105 price target. 2014 could be another rebuilding year for the company. 

bearishWaters downgraded at Mizuho

Oct 14, 2013 | 7:13 AM EDT

WAT was downgraded from Buy to Neutral, Mizuho said. $110 price target. See near-term choppiness in the pharmaceutical and diagnostic markets, following recent surveys. 

bullishWaters upgraded at Goldman

Jun 25, 2013 | 8:05 AM EDT

WAT was upgraded to Buy, Goldman Sachs said. $120 price target. Company is seeing better end-market demand. 


Doug Kass

 | Jun 25, 2013 | 7:49 AM EDT
Let's take a peek at overnight and early-morning price action.

bearishWaters downgraded at JP Morgan

Jan 3, 2013 | 8:21 AM EST

WAT was downgraded from Overweight to Neutral, JP Morgan said. Company is operating near peak margins and may face increased competition. 

bearishWaters downgraded at Leerink

Jan 3, 2013 | 7:57 AM EST

WAT was downgraded from Outperform to Market Perform, Leerink Swann said. Company may struggle to exceed consensus earnings expectations. 

Bobby Thanks for clarifying your strategy in Columnist Conversation -- that was sort of on...
Here is a preview before my Monday article posts. I'm showing time resistance to this mos...
As a buyer of options, I do not have the luxury of time. Options expire each week, each m...


News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.